Can Vaccinated People Spread the Delta Variant? - LatinAmerican Post latinamericanpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from latinamericanpost.com Daily Mail and Mail on Sunday newspapers.
Study shows efficacy of Pfizer-BioNTech and Moderna vaccines against SARS-CoV-2 delta variant
Researchers in Singapore have conducted a study showing that the messenger RNA- (mRNA) based coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna are highly effective at protecting against symptomatic and severe disease following infection with the rapidly spreading B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The team conducted a multi-center retrospective cohort study of vaccinated and unvaccinated individuals who had been admitted to hospital following infection with the B.1.617.2 variant of concern.
“To our knowledge, we provide the first data characterizing the impact of vaccination on virologic kinetics by the B.1.617.2 variant,” writes Barnaby Young from the National Centre for Infectious Diseases in Singapore and colleagues.
Even if you get sick, it ll be less serious : Vaccinated woman who got COVID-19 urges more to get their jabs channelnewsasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from channelnewsasia.com Daily Mail and Mail on Sunday newspapers.
Last Updated:
Singapore: One In 10 COVID Recovered Patients Suffer From Persistent Symptoms, Says Study
These recovered patients are described as the long haulers” and their condition is termed as the post-COVID-19 syndrome or long COVID-19”
IMAGE: AP
Months after their recovery, at least one in 10 patients of COVID-19 had persistent symptoms most commonly a lingering cough and shortness of breath in a condition described as the long COVID,” a new study published on July 10 has found. Scientists of the National Centre for Infectious Diseases (NCID) conducted a survey on the recovered COVID-19 patients in Singapore and discovered that nearly 6 months after the infections, many patients were in for a long haul as they struggled with fatigue, dizziness, and insomnia, which, in some cases, were not so frequently observed. There were, however, signs of the elevated inflammatory markers irrespective of whether or not the patient fought a severe or a mild case of the C
1406
Singapore, July 10
One in 10 recovered Covid-19 patients in Singapore had persistent symptoms six months after their initial infection, a study led by the National Centre for Infectious Diseases (NCID) has found.
In this condition, known as “long Covid”, they continued to experience symptoms, most commonly a lingering cough and shortness of breath, long after recovering from Covid-19. Other symptoms included persistent fatigue, dizziness and insomnia, but these were not frequently observed, The Straits Times reported on Saturday, citing the study by the country’s top infectious disease body which is focusing on Covid-19 treatment. The study also found elevated inflammatory markers regardless of whether the person had a serious or mild case of the disease. These proteins in the blood have been associated with conditions affecting the circulatory system and are a risk factor for cardiovascular disease.